Effectiveness of the Botulinum Toxin for Treating Sialorrhea in Patients with Parkinson's Disease: A Systematic Review

被引:25
作者
Antonio Ruiz-Roca, Juan [1 ]
Pons-Fuster, Eduardo [2 ]
Lopez-Jornet, Pia [3 ]
机构
[1] Univ Murcia, Dept Stomatol, Fac Dent, Murcia 30008, Spain
[2] IMIB, Res Invest, Murcia 30120, Spain
[3] Univ Murcia, Oral Med, Dept Stomatol, Fac Dent, Murcia 30008, Spain
关键词
botulinum toxin; sialorrhea; drooling; Parkinson's disease; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; SYMPTOMS; EFFICACY; SPEECH; SAFETY; SALIVA; SCALE;
D O I
10.3390/jcm8030317
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The main objective was to assess the efficacy of botulinum toxin-based treatment for sialorrhea in adult patients with Parkinson's disease. The search was performed by using the Medline-PubMed, EMBASE and Cochrane Library databases from January 2000-December 2017, in English/Spanish in patients with Parkinson's disease and sialorrhea. The methodological quality of trials was carried out by following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria and the Newcastle-Ottawa Scale (NOS). Finally, a total of 21 articles were identified as fulfilling the inclusion criteria. There is no consensus regarding the site of injection of the toxin (single or multiple points), toxin dose or follow-up period. In all cases there was a reduction of sialorrhea. Treatment safety increases with the use of ultrasonography. Effects approximately occur at one week post-injection and for 3-5 months. Botulinum toxin is an effective therapeutic strategy or option in treating sialorrhea in adult patients with Parkinson's disease. More studies with a better design, larger samples and a longer follow-up period are required to confirm these data.
引用
收藏
页数:12
相关论文
共 37 条
[1]   Ultrasound-guided botulinum toxin injections for treatment of drooling [J].
Breheret, R. ;
Bizon, A. ;
Jeufroy, C. ;
Laccourreye, L. .
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2011, 128 (05) :224-229
[2]   Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism [J].
Bruno, Veronica A. ;
Fox, Susan H. ;
Mancini, Deborah ;
Miyasaki, Janis M. .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2016, 43 (05) :697-702
[3]   Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease? [J].
Caline Nobrega, Ana ;
Rodrigues, Bernardo ;
Catarina Torres, Ana ;
Enzo, Alfredo ;
Melo, Ailton .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 253 (1-2) :85-87
[4]   Botulinum toxin in parkinsonism: The when, how, and which for botulinum toxin injections [J].
Cardoso, Francisco .
TOXICON, 2018, 147 :107-110
[5]   The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study [J].
Chaudhuri, Kallol Ray ;
Martinez-Martin, Pablo ;
Brown, Richard G. ;
Sethi, Kapil ;
Stocchi, Fabrizio ;
Odin, Per ;
Ondo, William ;
Abe, Kazuo ;
MacPhee, Graeme ;
MacMahon, Doug ;
Barone, Paolo ;
Rabey, Martin ;
Forbes, Alison ;
Breen, Kieran ;
Tluk, Susanne ;
Naidu, Yogini ;
Olanow, Warren ;
Williams, Adrian J. ;
Thomas, Sue ;
Rye, David ;
Tsuboi, Yoshio ;
Hand, Annette ;
Schapira, Anthony H. V. .
MOVEMENT DISORDERS, 2007, 22 (13) :1901-1911
[6]   International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study [J].
Chaudhuri, Kallol Ray ;
Martinez-Martin, Pablo ;
Schapira, Anthony H. V. ;
Stocchi, Fabrizio ;
Sethi, Kapil ;
Odin, Per ;
Brown, Richard G. ;
Koller, William ;
Barone, Paolo ;
MacPhee, Graeme ;
Kelly, Linda ;
Rabey, Martin ;
MacMahon, Doug ;
Thomas, Sue ;
Ondo, William ;
Rye, David ;
Forbes, Alison ;
Tluk, Susanne ;
Dhawan, Vandana ;
Bowron, Annette ;
Williams, Adrian J. ;
Olanow, Charles W. .
MOVEMENT DISORDERS, 2006, 21 (07) :916-923
[7]   Dihydroergotoxine mesylate for the treatment of sialorrhea in Parkinson's disease [J].
Cheng, Yong-Qing ;
Ge, Nian-Nian ;
Zhu, Hong-Hong ;
Sha, Zhi-Tao ;
Jiang, Teng ;
Zhang, Ying-Dong ;
Tian, You-Yong .
PARKINSONISM & RELATED DISORDERS, 2019, 58 :70-73
[8]   Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial [J].
Chinnapongse, Robert ;
Gullo, Kristen ;
Nemeth, Paul ;
Zhang, Yuxin ;
Griggs, Lynn .
MOVEMENT DISORDERS, 2012, 27 (02) :219-226
[9]   Pharmacological Treatment of Parkinson Disease A Review [J].
Connolly, Barbara S. ;
Lang, Anthony E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (16) :1670-1683
[10]   Volume matters: The influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis [J].
Evangelos, Anagnostou ;
Michael, Rentzos ;
Theodoros, Alexakis ;
Vasiliki, Zouvelou ;
Thomas, Zambelis ;
Ioannis, Evdokimidis .
MUSCLE & NERVE, 2013, 47 (02) :276-278